| 5Z5V: reference: Development and evaluation of a novel series of Nitroxoline-derived BET inhibitors with antitumor activity in renal cell carcinoma., Chen W, Zhang H, Chen Z, Jiang H, Liao L, Fan S, Xing J, Xie Y, Chen S, Ding H, Chen K, Jiang H, Luo C, Zheng M, Yao Z, Huang Y, Zhang Y, Oncogenesis. 2018 Nov 2;7(11):83. doi: 10.1038/s41389-018-0093-z. PMID: 30385738 |
This OCA 
Structure page
uses Jmol,
developed by the Jmol Development Team
(documentation).